ARA 290 vs KPV
Updated July 21, 2026 · Reviewed by the PeptidesDB Editorial team
A data-driven comparison of ARA 290 and KPV (also searched as KPV vs ARA 290) — effect profiles, evidence, side effects, and which suits weight loss, muscle, or healing goals.
Verdict
ARA 290 centers on neuro, while KPV leans toward healing. On indexed research, KPV is ahead (ARA 290: 4 studies, Preclinical; KPV: 6, Human evidence). Choose by goal — and read the primary studies. This is research information, not medical advice.
Key takeaways
- •ARA 290 is strongest for neuro; KPV for healing.
- •Evidence: ARA 290 Preclinical (4 studies) vs KPV Human evidence (6).
- •Both are research-use compounds — not FDA-approved.
Effect profiles, overlaid
At a glance
ARA 290 vs KPV: side-by-side
| Metric | ARA 290 | KPV |
|---|---|---|
| Class | Healing | Immune |
| Regulatory status | Research use only | Research use only |
| Evidence grade | Preclinical | Human evidence |
| Studies indexed | 4 | 6 |
| Research level | Extensively Studied | Emerging |
| Strongest effect | Neuro & mood | Healing & recovery |
| Healing & recovery | 2.3 | 4.0▲ |
| Muscle & body comp | 2.2▲ | 0.0 |
| Metabolic & appetite | 1.7▲ | 0.0 |
| Neuro & mood | 3.0▲ | 0.0 |
| Sleep & circadian | 1.0▲ | 0.0 |
| Inflammation & immune | 2.7 | 4.0▲ |
| Skin & aesthetics | 2.2▲ | 2.0 |
▲ marks the higher community effect score (0–5 perceived-effect signal, not clinical efficacy).
What is KPV?
### KPV Summary KPV is a tripeptide composed of lysine, proline, and valine, which has garnered interest in research for its potential roles in modulating immune responses and promoting wound healing. Its implications in various therapeutic contexts, particularly in inflammatory conditions, are currently being explored.
Full KPV profile, mechanism & studies →Which is better for your goal?
| Goal | Better fit | Why |
|---|---|---|
| Healing | KPV | 4.0/5 effect signal |
| Muscle | ARA 290 | 2.2/5 effect signal |
| Metabolic | ARA 290 | 1.7/5 effect signal |
| Neuro | ARA 290 | 3.0/5 effect signal |
| Sleep | ARA 290 | 1.0/5 effect signal |
| Inflammation | KPV | 4.0/5 effect signal |
| Skin | ARA 290 | 2.2/5 effect signal |
Fit reflects community-perceived effect profiles — not head-to-head trials. Read each peptide's studies before deciding.
Can you stack ARA 290 and KPV?
People sometimes combine peptides that target different pathways, but there is little controlled research on this specific pairing and the interactions aren't well characterized. Because neither compound is FDA-approved, we don't publish stacking or dosing protocols here. Any combination should be discussed with a qualified clinician.
ARA 290 vs KPV: side effects
No community-reported effects logged yet.
No community-reported effects logged yet.
Anonymous community reports (count = number of reports), not clinical incidence rates.
What the research says
ARA 290 has 4 approved studies indexed (Preclinical), and KPV has 6 (Human evidence). The Librarian re-checks PubMed, Europe PMC and ClinicalTrials daily, so these counts move. Open each profile to read the summaries and sources.
Frequently asked questions
Is ARA 290 or KPV better?
It depends on your goal. ARA 290 is strongest for neuro; KPV for healing. KPV has more indexed studies (6). See the goal-by-goal breakdown above.
Is ARA 290 or KPV better for weight loss?
ARA 290 shows the stronger metabolic & appetite profile (1.7/5) in community effect data — though weight-loss outcomes depend on the individual and the evidence base.
Is ARA 290 or KPV better for muscle?
ARA 290 leads on the muscle & body-composition axis (2.2/5).
Which has more research, ARA 290 or KPV?
ARA 290 has 4 approved studies indexed (Preclinical); KPV has 6 (Human evidence). Higher counts mean more to read, not proven superiority.
Can you stack ARA 290 and KPV?
Some users combine peptides, but there's little controlled data on this specific pairing, and interactions aren't well characterized. We don't publish stacking protocols for compounds that aren't FDA-approved. Discuss any combination with a qualified clinician.
What are the side effects of ARA 290 vs KPV?
ARA 290: no community-reported effects logged yet. KPV: none logged yet. These are anonymous reports, not incidence rates — see each profile.
Is ARA 290 or KPV FDA-approved?
ARA 290 is a research-use compound and is not FDA-approved. KPV is not FDA-approved. Research-use status is not a legal clearance to compound or use in humans.
Is KPV better than ARA 290?
For healing, KPV has the edge; for neuro, ARA 290 does. Neither is universally "better" — it's goal-dependent, and both should be weighed against their evidence base above.
Comparing related peptides
Regulatory & legal status
ARA 290 and KPV are research-use compounds and are not FDA-approved for human use. FDA approval and compounding rules for peptides change frequently, and research-use status is not a legal clearance for human use. The FDA does not review compounded drugs for safety, effectiveness, or quality. Verify current status with primary sources before acting. Last reviewed July 21, 2026.